Form D Explorer

Form D — TNF Pharmaceuticals, Inc.

0001641172-25-026761 · filed Sep 5, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
06b
Reported offering amount
$7,000,000
Reported amount sold
$7,000,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
TNF Pharmaceuticals, Inc.
CIK
1321834
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2023
Address
1185 AVENUE OF THE AMERICAS
NEW YORK, NY 10036
Phone
856-848-8698

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗